CD5 is a sterile formulation of CJC‑1295 with Drug Affinity Complex (DAC) at 5 mg per 10 mL vial supplied as a pack of 10 vials. CJC‑1295 is a synthetic growth‑hormone‑releasing hormone (GHRH) analogue engineered with a DAC to extend systemic half‑life and prolong GH‑releasing activity in preclinical models. The product is intended for in vitro and preclinical research into somatotropic axis signalling, GH/IGF‑1 pathway modulation, receptor pharmacology, and cellular responses to prolonged GHRH‑like stimulation. Exact excipients, formulation vehicle, sterility/endotoxin status, and stability/expiry are batch‑specific and provided on the Certificate of Analysis.Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
